​

Surgery Partners (SGRY) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

SGRY Stock Forecast

Surgery Partners (SGRY) stock forecast, based on 22 Wall Street analysts, predicts a 12-month average price target of $18.75, with a high of $21.00 and a low of $17.00. This represents a 32.79% increase from the last price of $14.12.

$10 $15 $20 $25 $30 $35 High: $21 Avg: $18.75 Low: $17 Last Closed Price: $14.12

SGRY Stock Rating

Surgery Partners stock's rating consensus is Buy, based on 22 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 14 Buy (63.64%), 8 Hold (36.36%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 22 0 8 14 Strong Sell Sell Hold Buy Strong Buy

SGRY Price Target Upside V Benchmarks

TypeNameUpside
StockSurgery Partners32.79%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks15.52%

Price Target Trends

1M3M12M
# Anlaysts2211
Avg Price Target$18.50$18.50$19.57
Last Closing Price$14.12$14.12$14.12
Upside/Downside31.02%31.02%38.60%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 26183--12
Aug, 26183--12
Jul, 26183--12
Jun, 26183--12
May, 26183--12
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 11, 2026Sarah JamesRaymond James$18.00$15.3417.34%27.48%
Aug 11, 2026RBC Capital$19.00$15.9519.12%34.56%
May 06, 2026Jefferies$17.00$14.8314.63%20.40%
Apr 20, 2026Jefferies$15.00$14.275.12%6.23%
Mar 11, 2026US Capital Advisors$21.00$13.5055.56%48.73%
Mar 04, 2026Brian TanquilutJefferies$16.25$14.2713.88%15.08%
Mar 04, 2026Ben HendrixRBC Capital$20.00$14.2240.65%41.64%
Mar 03, 2026Jefferies$30.00$13.41123.71%112.46%
Dec 18, 2025Mizuho Securities$19.00$15.8020.25%34.56%
Nov 21, 2025Barclays$18.00$15.3017.65%27.48%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 11, 2026Cantor FitzgeraldOverweightOverweighthold
Aug 11, 2026BenchmarkBuyBuyhold
Aug 11, 2026Cowen & Co.BuyBuyhold
May 06, 2026JefferiesBuyBuyhold
Mar 11, 2026UBSBuyBuyhold
Mar 04, 2026JefferiesBuyBuyhold
Mar 04, 2026Cantor FitzgeraldOverweightOverweighthold
Mar 04, 2026RBC CapitalOutperformOutperformhold
Mar 03, 2026BenchmarkBuyBuyhold
Nov 14, 2024Cowen & Co.BuyBuyhold

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-1.12$-0.59$-0.09$-1.33$-0.61--
Avg Forecast$-0.15$0.11$0.93$0.85$0.96$1.21$1.75
High Forecast$-0.15$0.12$0.96$0.98$1.17$1.35$1.78
Low Forecast$-0.15$0.11$0.89$0.76$0.72$0.95$1.73
Surprise %646.67%-636.36%-109.68%-256.47%-163.54%--

Revenue Forecast

$2B $3B $3B $4B $4B $5B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$2.23B$2.54B$2.74B$3.11B$3.31B--
Avg Forecast$2.24B$2.52B$2.75B$3.08B$3.39B$3.70B$4.12B
High Forecast$2.26B$2.55B$2.79B$3.12B$3.44B$3.70B$4.18B
Low Forecast$2.22B$2.50B$2.72B$3.07B$3.36B$3.70B$4.08B
Surprise %-0.59%0.75%-0.24%1.19%-2.31%--

Net Income Forecast

$-200M $-110M $-20M $70M $160M $250M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-70.90M$-54.60M$-11.90M$-168.10M$-77.90M--
Avg Forecast$-86.91M$-58.15M$-11.90M$109.27M$118.76M$134.00M$220.40M
High Forecast$-69.53M$-42.53M$-8.70M$123.37M$147.04M$169.40M$223.98M
Low Forecast$-104.29M$-73.77M$-15.10M$95.17M$90.48M$118.74M$216.82M
Surprise %-18.42%-6.10%--253.84%-165.60%--

SGRY Forecast FAQ

Is Surgery Partners stock a buy?

Surgery Partners stock has a consensus rating of Buy, based on 22 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 14 Buy, 8 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Surgery Partners is a favorable investment for most analysts.

What is Surgery Partners's price target?

Surgery Partners's price target, set by 22 Wall Street analysts, averages $18.75 over the next 12 months. The price target range spans from $17 at the low end to $21 at the high end, suggesting a potential 32.79% change from the previous closing price of $14.12.

How does Surgery Partners stock forecast compare to its benchmarks?

Surgery Partners's stock forecast shows a 32.79% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical care facilities stocks industry (15.52%).

What is the breakdown of analyst ratings for Surgery Partners over the past three months?

  • September 2026: 8.33% Strong Buy, 66.67% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 8.33% Strong Buy, 66.67% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 8.33% Strong Buy, 66.67% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Surgery Partners’s EPS forecast?

Surgery Partners's average annual EPS forecast for its fiscal year ending in December 2026 is $1.21, marking a -298.36% decrease from the reported $-0.61 in 2025. Estimates for the following years are.

What is Surgery Partners’s revenue forecast?

Surgery Partners's average annual revenue forecast for its fiscal year ending in December 2026 is $3.7B, reflecting a 11.85% increase from the reported $3.31B in 2025. The forecast for.

What is Surgery Partners’s net income forecast?

Surgery Partners's net income forecast for the fiscal year ending in December 2026 stands at $134M, representing a -272.02% decrease from the reported $-77.9M in 2025. Projections indicate .